# Criteria Bio Ventures

> Criteria Bio Ventures is a VC fund backing Biotechnology and Life Science. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 7
- Last investment: May 2026
- Lead investor: 43%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/criteria-bio-ventures
- Website: https://www.criteriabioventures.com

Criteria Bio Ventures is a VC fund in Barcelona focused on Biotechnology and Life Science. Criteria Bio Ventures Life Sciences venture fund backing private biotech companies in Europe and North America with a special focus on Spain and Portugal.

## Contacts

5 contacts available for Criteria Bio Ventures. Shizune tracks 1 team members at Criteria Bio Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/criteria-bio-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Pre-Seed | $3.5M–$3.5M |
| Series A | $29M–$83M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 57% |
| Life Science | 2 | 29% |
| Medical | 1 | 14% |
| Health Care | 1 | 14% |
| Therapeutics | 1 | 14% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 14% |
| Pre-Seed | 1 | 14% |
| Series A | 1 | 14% |
| Series B | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 2 | 29% |
| Spain | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Pablo Cironi | Managing Director | 5 | https://shizune.co/investors/profile/pablo-cironi-8645 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cytospire Therapeutics | Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers. | $82.6M | Series A | May 05, 2026 |  |
| Adaptam Therapeutics | Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies | $3.5M | Pre-Seed | Oct 27, 2025 |  |
| Adaptam Therapeutics | Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies | $3.5M | Pre-Seed | Oct 27, 2025 |  |
| NRG Therapeutics | NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and motor neurone disease. Founded in 2018 by a team of experienced biotech and pharmaceutical industryprofessionals, with a background in neuroscience drug discovery, NRG Therapeutics will initially focus on the discovery and development of brain penetrant mitochondrial permeability transition pore inhibitors for the treatment of Parkinson’s disease. | $67.8M | Series B | Sep 08, 2025 |  |
| Tolerance Bio | Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases thymus. | $20.2M | Seed | Oct 15, 2024 |  |
| Medlumics | Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology. |  | Venture - Series Unknown | Jul 29, 2024 |  |
| AbolerIS Pharma | AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance. | $29.2M | Series A | Sep 18, 2023 |  |

7 of 7 investments shown.

## Co-investors
- [British Business Bank](https://shizune.co/investors/profile/british-business-bank) — VC Fund, 2 deals together
- [Criteria Venture Tech](https://shizune.co/investors/profile/caixa-capital) — VC Fund, 2 deals together
- [Omega Funds](https://shizune.co/investors/profile/omega-funds) — VC Fund, 2 deals together
- [Sound Bioventures](https://shizune.co/investors/profile/sound-bioventures) — VC Fund, 2 deals together
- [4BIO Capital](https://shizune.co/investors/profile/4bio-capital-partners) — VC Fund, 1 deal together
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Life Science Investors in Spain](https://shizune.co/investors/life-science-investors-spain)

## FAQ

### What does Criteria Bio Ventures invest in?

Criteria Bio Ventures invests primarily in Biotechnology, Life Science and Medical startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Criteria Bio Ventures's check size?

Criteria Bio Ventures typically joins rounds of $3.5M–$3.5M at Pre-Seed and $29M–$83M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Criteria Bio Ventures participates in.

### How do I contact Criteria Bio Ventures?

Public channels for Criteria Bio Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Criteria Bio Ventures?

The team at Criteria Bio Ventures includes Pablo Cironi (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co